Haleon plc

Haleon plc is a British multinational consumer healthcare company headquartered in Weybridge, England. It was established on 18 July 2022 as a corporate spin-off from GlaxoSmithKline plc and Pfizer Inc. The company is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Haleon offers a wide range of consumer healthcare products, including oral health products, pain relief medications, and vitamins and supplements. In March 2025, Pfizer sold its entire stake in Haleon for approximately $3.24 billion, making BlackRock Investment Management (UK) Ltd the largest shareholder with over a 5% stake. GSK had previously sold its entire stake in May 2024.